Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 19, 2011

View Archived Issues

Photocross-linked biosynthetic implants provide new tool for soft tissue reconstruction

Scientists genetically engineer E. coli to detect and kill P. aeruginosa

Human monoclonal antibody neutralizes influenza A group 2 viruses

Ranbaxy discloses new DPP IV/ACE inhibitors

New antitumor agents synthesized by Kyowa Hakko Kirin

Vertex discloses new inhibitors of PKC-theta

Novel antitumor agents disclosed by Chinese and U.S. team

New vitamin D analogues claimed

Cynapsus provides update on proposed acquisition of Adagio Pharmaceuticals

Afexa Life Sciences reports on LIP-01 trial in cholesterol management

Adamas Pharmaceuticals begins phase II/III study of ADS-5102

Shionogi advances acquisition of C&O Pharmaceutical Technology

Endo Pharmaceuticals terminates collaboration with Gruenenthal

FDA grants fast track status to DARA's KRN-5500

Kinex Pharmaceuticals begins phase I trial of KX2-391 in AML

Curis doses first patient in CUDC-101 head and neck cancer study

MAA accepted and NDA submitted for ridaforolimus

Hydrogen sulfide replacement may protect against complications of diabetes

Phase II trial of Cell Therapeutics' Opaxio opens enrollment

Furiex closes loan agreement to support development of clinical-stage products

NPS Pharmaceuticals submits CMC section of Gattex NDA to FDA

Antigen Express presents phase II data on anticancer vaccine AE-37 in breast cancer

FDA clears IND to conduct clinical studies of lasmiditan

FDA approves Marshall Edwards' IND for lead NADH oxidase inhibitor

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...